People · Operator
Named in public records as an officer, director or promoter · active 2006–2025 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Instylla, Inc. | — | Biotechnology | Series B | $85.5M | $100.2M | 2025 |
| Ocular Therapeutix, Inc | — | Biotechnology | Series B | $81.0M | $1.5B | 2006 |
| Augmenix Inc | — | Biotechnology | Series A | $40.6M | $216.9M | 2008 |
| Apperian, Inc. | — | Other Technology | Series A | $37.2M | $343.5M | 2009 |
| Quovo, Inc. | — | Other Technology | Seed | $4.9M | $129.5M | 2015 |
Steven Cagnetta at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steven Cagnetta on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| FARHAD KHOSRAVI | 3 | 14 |
| Amarpreet Sawhney | 3 | 8 |
| Tara Butler | 2 | 12 |
| Patrick Campbell | 2 | 4 |
| Tasneem Dohadwala | 2 | 2 |
| Robert Goodman | 1 | 13 |
| Richard Lindstrom | 1 | 13 |
| Michael Skok | 1 | 12 |
| Alan Crane | 1 | 9 |
| Richard L Lindstrom | 1 | 8 |
| Brian Levy | 1 | 8 |
| Henry Chen | 1 | 7 |
| James Garvey | 1 | 6 |
| Maia Heymann | 1 | 6 |
| Charles Warden | 1 | 5 |
| Darshana Zaveri | 1 | 5 |
| VINIT NIJHAWAN | 1 | 3 |
| Brian Day | 1 | 3 |
| BARRY GOLDMAN | 1 | 2 |
| Daniel Myers | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.